More definite evidence that a genetically determined increase in NLRP3 inflammasome activity and excessive production of IL-1β is the cause of IBD (Crohn's disease) has come from studies of patients with a loss-of-function mutation in CARD8, a protein previously shown to inhibit the NLRP3 inflammasome (44). The gene discussed is IL1B; the disease is inflammatory bowel disease.